Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
Figure 3
Hypoxia was significantly reduced 1 week after therapy with 1 μg intravitreal melphalan and after administration of maximum concentration of subconjunctival melphalan.
